A Fatality Involving Clomipramine - Library

FRASER ET AL ~ FATALITY INVOLVING CLOMIPRAMINE 767
[7] Spiker, D. G., "The Toxicity of Tricyclic Antidepressants," Communications in Psychopharmacol-
ogy, Vol. 2, May 1978, pp. 419-427.
[8] Rose, J. B., "Tricyclic Antidepressant Toxicity," Clinical Toxicology, Vol. 11, No. 4, April 1977,
pp. 391-402.
[9] Stevenson, A. J. and LaDelpha, S., "Tricyclic Antidepressants--An 18 Month Experience," Bulle-
tin of the International Association of Forensic Toxicologists, Vol. 16, No. 3, July 1982, pp. 12-1.5.
I10] Haggai, M. T. and Gutteridge, D. R., "Two Cases of Clomipramine Hydrochloride (Anafranil)
Poisoning," Forensic Sciences, Vol. 3, No. 1, Jan. 1974, pp. 83-87.
[11] Meatherall, R. C., Guay, D. R. P., and Chalmers, J. L., "A Fatal Overdose with Clomipramine,"
Journal of Analytical Toxicology, Vol. 7, No. 4, July/Aug. 1983, pp. 168-171.
[12] Davidow, B., Petri, N. L., and Quame, B., "A Thin Layer Chromatographic Procedure for Detect-
ing Drugs of Abuse," American Journal of Clinical Pathology, Vol. 50, No. 6, Dec. 1968, pp. 714-719.
[13] Higgins, G. and Leach, H., "Screening Tests for Common Drugs," in Isolation and Identification of
Drugs in Pharmaceutical, Body Fluids and Post-Mortem Material. E. G. C. Clarke, Ed., The Phar-
maceutical Press, London, 1975, p. 896.
[141 Moffatt, A. C., "Alprazolam Case," Toxilogic, Vol. 8, Dec. 1982, p. 7.
[15] Machata, G., "Determination of Alcohol in Blood by Gas Chromatography--Head Space
Analysis," Clinical Chemistry Newsletter, Vol. 4, No. 2, March 1972, pp. 29-32.
[16] National Psychopharmacology Laboratory Inc., 9401 Parkwest Blvd., Knoxville, TN, 1984.
[17] Montgomery, S. A., Montgomery, D. B., McAulay, R., Dawling, S., and Braithwaite, R. A.,
"Plasma Concentration of Clomipramine and N-Desmethylclomipramine and Clinical Response in
Depressed Patients," Postgraduate Medical Journal, Vol. 56, Suppl. D, April 1980, pp. 130-133.
[18] Miller, M. B., Fones, R. B., Seldrup, J., Beaumont, G., and John, V., "Relationships Between
Clinical Response, Plasma Levels and Side Effects of Clomipramine (Anafranil) in General Practi-
tioner Trials," Journal of International Medical Research, Vol. S, Suppl., June 1977, pp. 108-118.
[191 Broadhurst, A. D., James, H. D.. Della Corte, L., and Heeley, A. F., "Clomipramine Plasma Level
and Clinical Response," Postgraduate Medical Journal, Vol. 53, Suppl. 4, Aug. 1977, pp. 139-145.
[20] Baselt, R. C., "Disposition of Toxic Drugs and Chemicals in Man," second ed., Biomedical Publi-
cations, Davis, CA, 1982, pp. 182-184 and 299-303.
[21] McCormick, S. R., Nielson, J., and Jatlow, P., "Quantification of Alprazolam in Serum or Plasma
by Liquid Chromatography," Clinical Chemistry, Vol. 30, Oct. 1984, pp. 1652-1655.
[22] Abernethy, D. R., Greenblatt, D. J., Divoll, N., and Shader, R. J., "Pharmacokinetics of Alpra-
zolam," Journal of Clinical Psychiatry, Vol. 44, Jan. 1983, pp. 45-47.
[23] Drug Experience Unit, Upjohn Company, Kalamazoo, MI, 1985.
[24] Ueki, S., Watanabe, S., Yamamoto, T., Kataoka, Y., Tazoe, N., Shibata, S., Ohta, H., Kauahara,
K., Takano, M., Suwandi, D., Lee, S. C., and Liow, S. X., "Behavioral and Electroencephalo-
graphic Effects of Alprazolam and Its Metabolites,'* Nippon-Yakurisaku Zasshi, Vol. 77, May
1981, pp. 483-509.
Address requests for reprints or additional information to
Dr. A. D. Fraser
Head, Toxicology Laboratory
Victoria General Hospital
1278 Tower Rd.
Halifax, Nova Scotia, Canada B3H 2Y9